| |
| |
|
| Insider
Information: |
Abernethy Matt |
| Relationship: |
Chief Financial Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
31,528 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,287,493 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,528 |
|
|
| Total
Value |
$4,287,493 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Financial Officer |
2024-02-13 |
31,528 |
2018-12-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2024-02-13 |
4 |
AS |
$132.85 |
$179,612 |
D/D |
(1,352) |
31,528 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2024-02-08 |
4 |
AS |
$134.21 |
$131,529 |
D/D |
(980) |
30,314 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2024-02-06 |
4 |
AS |
$142.19 |
$182,000 |
D/D |
(1,280) |
29,434 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2024-01-31 |
4 |
AS |
$140.72 |
$180,539 |
D/D |
(1,283) |
28,284 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2023-08-21 |
4 |
AS |
$107.39 |
$228,958 |
D/D |
(2,132) |
27,131 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2023-02-08 |
4 |
AS |
$104.19 |
$102,110 |
D/D |
(980) |
25,213 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2023-02-07 |
4 |
AS |
$102.33 |
$2,696,107 |
D/D |
(26,328) |
24,333 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2023-02-06 |
4 |
AS |
$105.67 |
$135,253 |
D/D |
(1,280) |
22,507 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2023-01-31 |
4 |
AS |
$109.98 |
$141,108 |
D/D |
(1,283) |
21,357 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2022-02-08 |
4 |
AS |
$79.65 |
$78,058 |
D/D |
(980) |
20,204 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2022-02-07 |
4 |
AS |
$80.78 |
$267,428 |
D/D |
(3,310) |
19,325 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2021-12-01 |
4 |
AS |
$82.59 |
$135,852 |
D/D |
(1,645) |
16,349 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2021-02-08 |
4 |
AS |
$116.81 |
$339,942 |
D/D |
(2,910) |
14,869 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2020-12-01 |
4 |
AS |
$94.66 |
$155,721 |
D/D |
(1,645) |
11,494 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2020-11-12 |
4 |
AS |
$90.74 |
$204,810 |
D/D |
(2,257) |
10,014 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2020-08-05 |
4 |
AS |
$118.90 |
$268,356 |
D/D |
(2,257) |
7,983 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2020-05-07 |
4 |
OE |
$73.60 |
$1,104,000 |
D/D |
15,000 |
20,953 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2020-05-07 |
4 |
AS |
$110.21 |
$1,653,134 |
D/D |
(15,000) |
5,953 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2020-04-28 |
4 |
AS |
$102.49 |
$178,435 |
D/D |
(1,741) |
5,953 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2020-04-24 |
4 |
AS |
$99.52 |
$192,467 |
D/D |
(1,934) |
7,694 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2020-02-07 |
4 |
AS |
$103.35 |
$209,807 |
D/D |
(2,030) |
5,701 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2019-12-02 |
4 |
AS |
$116.33 |
$191,360 |
D/D |
(1,645) |
3,876 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Financial Officer |
• – – |
2018-12-03 |
4 |
AS |
$90.00 |
$106,020 |
D/D |
(1,178) |
1,947 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
